NCT06229366
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06229366
Title [Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer (ACCEL)
Acronym ACCEL
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
Juravinski NOT_YET_RECRUITING Hamilton L8V 5C2 Canada Details
Jewish General Hospital NOT_YET_RECRUITING Montreal H3T 1E2 Canada Details
McGill University RECRUITING Montreal H4A 3J1 Canada Details
Centre Hospitalier Universite de QUEBEC RECRUITING Québec G1J 1Z4 Canada Details
Hopital De Chicoutimi NOT_YET_RECRUITING Saguenay G7H 5H6 Canada Details
Princess Margaret Cancer Centre RECRUITING Toronto M5G 2M9 Canada Details
BC Cancer Vancouver RECRUITING Vancouver V5Z4E6 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field